Strontium Citrate: The Definitive Guide

What is Strontium Citrate?

Strontium citrate has no standalone fracture-prevention trial. Strontium in bone can also make DXA density readings look higher. No U.S. RDA, AI or established routine supplement regimen exists for strontium. Prescription strontium ranelate evidence and risks must not be transferred to citrate.

Typical Strontium Citrate Protocols

These rows reproduce sources. Do not average them into one universal regimen.

Which forms and label details matter?

Record the salt, elemental strontium declared, citrate mass if separately stated, co-ingredients, calcium exposure, kidney function and product licence. Salt mass and elemental strontium are not interchangeable without a verified conversion.

How should it be stored?

Follow the label, close the container and protect it from heat, light and moisture.

What is it commonly used for?

It is marketed for bone density. The direct citrate clinical signal comes mainly from a multi-ingredient regimen, while fracture prevention remains unestablished and DXA interpretation is confounded.

What does human research show?

MOTS tested a nightly combination of strontium citrate 450 mg, melatonin 5 mg, vitamin D3 2,000 IU and vitamin K2 MK-7 60 mcg for one year in postmenopausal women with osteopenia. Lumbar-spine and femoral-neck BMD rose relative to placebo, but the trial cannot assign the result to strontium citrate alone and did not establish standalone fracture prevention. [1] A phantom study showed that strontium changes X-ray attenuation and can overestimate DXA-derived BMD; apparent scan gains are therefore not a one-to-one measure of stronger bone. [2] Health Canada’s safety review found insufficient information to determine whether cardiovascular risk seen with ranelate applies to non-ranelate salts and required cautionary product measures; uncertainty is not proof of safety. [3] A broader review describes plausible bone-remodelling mechanisms but confirms that the strongest clinical outcome evidence concerns other strontium salts, not standalone citrate. [4]

How might it act?

Biological plausibility does not establish a clinical outcome. The guide therefore keeps preparation, population and endpoint attached to each result.

How does it compare with related products?

What are the risks and interactions?

Avoid self-treatment of osteoporosis. Review cardiovascular or thromboembolic disease, uncontrolled hypertension, kidney impairment, pregnancy, breastfeeding and all bone medicines. Tell the imaging clinician before DXA interpretation. Calcium and strontium share absorption pathways, but no universal separation schedule is established for citrate.

Which medicines require review?

Have the product reviewed with medicines, before surgery, and during pregnancy or breastfeeding. No universal separation interval is established.

Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [5], [6]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.

What happens when it is stopped?

No ingredient-specific withdrawal syndrome is established. Record the stop date, symptoms and chosen outcome; seek care for a persistent serious symptom.

Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.

What do public communities report?

Public reports can suggest questions to track, but they do not verify the product, dose or causality. This update did not newly quantify a community sample.

Common questions about Strontium Citrate

Does strontium citrate prevent fractures?

No standalone human fracture-prevention evidence establishes that claim.

Can I use ranelate trials to judge citrate?

No. Salt, prescription status, formulation and safety context differ.

Why can DXA look better?

Strontium attenuates X-rays more strongly than calcium, inflating the derived density.

What did MOTS test?

A four-ingredient nightly regimen, not isolated strontium citrate.

Should calcium be separated?

Competition is plausible, but the exact product and clinical context should determine timing; no universal citrate interval is established.

What should I track?

Elemental strontium, salt, co-ingredients, kidney and cardiovascular context, calcium, DXA disclosure and fracture outcomes.

Glossary

Terms for reading the evidence.

Formulation

The chemical form, source and finished delivery system used in a study.

Daily total

The sum across administrations; it does not reveal amount each time.

WOMAC

A questionnaire for osteoarthritis pain, stiffness and physical function.

DXA

Dual-energy X-ray absorptiometry; some materials can alter the reading itself.

Subgroup

A subset analysis that usually carries more uncertainty than the primary result.

Clinical outcome

A change in symptoms, function or events rather than only a laboratory marker.

How this guide was researched

Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources